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BACKGROUND: Based on 'vascular disorder of pregnancy' terminology, preeclampsia primarily was not a hypertensive disorder, but a vascular 
disorder (general vasospasm) in pregnancy due to idiopathic 
etiology. The overall incidence of preeclampsia was 5-14% 
of all pregnancies. One of the substances responsible 
for regulating vascular tone is nitric oxide (NO), which 
produced in endothelial blood vessels. NO and L-citrulline 
are produced altogether by the reaction between L-arginine 
and oxygen. L-citrulline levels reflected NO production. 
This study was aimed to assess the correlation between the 
L-citrulline level and blood pressure in severe preeclampsia.
METHODS: This cross-sectional study was done in Dr. M. 
Djamil Central General Hospital, Padang, Indonesia The 
sample size was 36 samples of pregnant women with severe 
preeclampsia and had yet been given antihypertensive 
therapy. Sampling was done by consecutive sampling 
from Obstetrics and Gynecology Division. After maternal 
examination and measurements L-citrulline levels of cubital 
venous blood by using enzyme-linked immunosorbent 
assay (ELISA) method, Pearson correlation was performed 
to assess the relationship between variables for normally 
distributed data and Spearman's correlation for abnormal 
distribution data with significance level p<0.05.
RESULTS: Means of L-citrulline levels, systolic blood 
pressure, diastolic blood pressure, and arterial pressure 
(MAP) were 87.21 nmol/mL, 179.4 mmHg, 108.3 
mmHg, and 132.1 mmHg, respectively. Correlation of the 
L-citrulline level with systolic blood pressure, diastolic 
blood pressure, and MAP were -0.08, -0.175, and -0.136 
(p>0.05), respectively.  
CONCLUSION: L-citrulline levels had no correlation with 
blood pressure in severe preeclampsia.
KEYWORDS: L-citrulline levels, blood pressure, severe 
preeclampsia
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Abstract
Introduction
Preeclampsia is one of maternal mortality main causes until 
today besides bleeding and infection. The overall incidence 
of preeclampsia was 5-14% of all pregnancies. It was 
later found out that the incidence of preeclampsia is about 
15.9% of all maternal deaths in the United States and was 
the greatest causes of perinatal morbidity and mortality. Its 
exact etiology which had yet been elucidated had caused 
primary prevention and casual therapy to be difficult, 
therefore controlling its morbidity and mortality was proven 
to be a challenge.(1)
 Preeclampsia had been found worldwide with a varied 
incidence between 2%-8% (2), with a mean of 4.6% (1). 
While in developing countries, this was varied between 
1.8%-16.7%.(3) The incidence reported in Indonesia was 
still dominated by the hospital-based reports. Prevalence of 
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preeclampsia in Dr. Cipto Mangunkusumo National Central 
General Hospital, Jakarta, Indonesia was 16.6% (4), while 
in Dr. M. Djamil Central General Hospital  was 7.1% (5).
 Nitric oxide (NO) was produced from L-Arginine 
and O2 reaction catalyzed by NO synthase (NOS) enzyme. 
Another product of this reaction was L-citrulline. NOS 
enzyme activity stimulates NO production during pregnancy. 
The up-regulation of NO roles in pregnancy was due to 
the increase of estrogen level.(6) Physiologic disturbance 
of NO was the main etiology cause of preeclampsia, 
therefore, the administration of exogenous NO was being 
an interesting treatment option to be done.(7) Disturbances 
in  NO  production  caused  the  imbalance  of  reactive 
oxygen species (ROS) and NO which subsequently causing 
dysfunction of vasodilation, therefore, blood pressure tends 
to increase.(6)
 The measurement of NO levels was so difficult 
to  be  done  due  to  its  extremely  short  half-life.  NO 
was immediately reduced to nitrite and nitrate anion 
(both were called NO metabolites). Measurement of both 
metabolites was used as a surrogate measurement of NO 
production by endothelial NOS enzymes.(8) Then, NO and 
L-citrulline were both end products of L-arginine and O2 
reaction catalyzed by NOS enzyme, bearing in mind that 
if this reaction was adequately produced by enough NO 
and L-citrulline, vice versa. L-citrulline levels reflected 
NO production.(9) Based on the facts above, this study was 
done to assess the correlation between L-citrulline level and 
blood pressures in severe preeclampsia.
Methods
Samples Selection and Recruitment
This research was an observational analytic study with 
cross sectional study design, that was conducted during 
four month from November – February 2019. This study 
was assessing correlation of L-citrulline levels with blood 
pressure before administration of antihypertensive and 
anticonvulsant drugs. As determined with Federer formula, 
a sample size of 36 samples was done by consecutive 
sampling of preeclampsia case admitted to hospital and 
had no antihypertensive and anticonvulsive drugs which 
had met inclusion criteria and passed exclusion criteria. 
The inclusion criteria in this study were all women with 
preeclampsia, had no antihypertensive and anticonvulsive 
drugs before. Sampling was done by consecutive sampling, 
taken from Obstetrics and Gynecology Division of Dr. M. 
Djamil Central General Hospital, Padang, Indonesia.
 All patients signed the informed consent and filled the 
history questionnaire before the clinical examination and 
obstetric examination were performed. This research has 
passed the ethical clearance test from Ethics Committee, 
Faculty of Medicine, Universitas Andalas (No. 362/KEP/
FK/2018). 
Clinical and Obstetric Examination
After signing informed consent, history, clinical examination 
and obstetric examination, and ultrasound were performed. 
Blood pressure was obtained and then mean arterial pressure 
(MAP) was calculated. 
Enzyme-linked Immunosorbent Assay (ELISA) 
Examination
Three mL of cubital venous blood was withdrawn to 
measure L-citrulline levels in serum using Cusabio reagent 
(Catalogue #CSB-E13832h, Houston, USA) and Bio-Rad 
electrophoresis with ELISA method. 
Statistical Analysis
Statistical analysis was performed using SPSS (IBM 
Corporation, New York, USA). Univariate analysis 
was used to observe the characteristics of respondents. 
Bivariate analysis was done using Pearson correlation test 
if data distribution was normal and Spearman correlation 
test was used when data distribution was not normal with 
significance level p<0.05. The normality test was assessed 
using Shapiro-Wilk test (total sample in group less than 50).
Results
The maternal age was ranged between 20-44 years old 
with patients mean age was 31.9 years old. The mean of 
gestational age was 33.6 weeks. Table 1 showed that most 
of the samples were multipara (72.2%) and more than half 
was a late onset of preeclampsia (52.8%).
 The mean of subjects’ L-citrulline level was 87.21 
nmol/mL, meanwhile the mean of systolic blood pressure, 
diastolic blood pressure, and MAP were 179.4 mmHg, 
108.3 mmHg, and 132.1 mmHg, respectively (Table 2).
 Table 3 showed the correlation of L-citruline level 
and blood pressure. L-citruline level had a weak negative 
correlation with systolic blood pressure, diastolic blood 
pressure, and MAP, respectively. L-citruline level had no 
significant correlation with systolic blood pressure, diastolic 
blood pressure, and MAP, whereas these three maternal 
outcome parameters had p>0.05.
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Preeclampsia onset  
Table 1. Characteristics of parity and preeclampsia 
onset.
Variable Mean±SD Min Max 
 L-citrulline levels (nmol/mL) 87.21±57.79 1.2 156.3
 Systolic blood pressure (mmHg) 179.4±24.8 160 270
 Diastolic blood pressure (mmHg) 108.3±15.8 90 150
 Mean arterial pressure  (mmHg) 132.1±17.5 113 190
Table 2. L-citrulline levels and blood pressure.
Mean L-citrulline levels in this study was 87.21 nmol/mL, 
or 87.21 µmol/L. This finding was twice of a healthy person, 
hat is 35.19 µmol/L.(8) This finding was also higher than 
previous report, where levels of severe preeclampsia from 17 
subjects was 44.1 µmol/L.(9) Plasma levels of L-citrulline, 
which reflect NO production, are significantly higher in 
women with severe preeclampsia than in normotensive 
pregnant women.(9) High L-citrulline level found in 
severe preeclampsia in this study seemed in contrast with 
the hypothesis that L-citrulline levels in preeclampsia 
should be lower than in normal healthy persons. This 
fact could happen since this L-citrulline level reflected 
high production of NO, and high production of NO is a 
compensation phenomenon to the increased synthesis and 
release of vasoconstrictor and platelet-aggregating agents 
in severe preeclampsia.(9) The increase of synthesis and 
release of vasoconstrictor and platelet-aggregating agents 
mainly occurred in placental preeclampsia, therefore it is 
possible that (most of) preeclampsia cases being this study 
subjects had main etiopathogenesis of placental factor and 
not a vascular factor. 
Discussion
 In this study, the mean systolic pressure was 179.4 
mmHg and diastolic pressure was 108.3 mmHg. This 
findings indicated that (most of) these study subjects 
were categorized as severe preeclampsia, fulfilling criteria 
systolic blood pressure >110 mmHg, and not due to diastolic 
pressure of >110 mmHg, which means that systolic pressure 
increase was more prominent than diastolic pressure in this 
study subjects; or in other words, there was no large increase 
in diastolic pressure. 
 NO had crucial roles in endothelial regulation, 
controlling blood pressure, and cardiovascular haemostasis.
(10) NO caused vascular relaxation and suppressed 
thrombocyte adhesion to vascular endothelial.(7,11) This 
effect was mediated by 3',5'-cyclic guanosine monophosphate 
(cGMP) produced by soluble guanylyl cyclase,  cGMP 
activated  protein  kinase A  (PKA)  and protein kinase G 
(PKG). Activated PKA and PKG induced smooth  muscle 
relaxation  by attenuating  myosin light chain kinase 
activity and enhancing myosin light chain phosphatase 
activity   (6,12),  which  resulted  in  the  decrease  of 
muscle contraction strength through two mechanisms, i.e., 
decreased Ca2+ level or decreased sensitivity to Ca2+ (13).
 One substance that plays an important role in 
regulating blood pressure generated is endothelial-derived 
endothelial nitric oxide (eNO), or also knows as NOS3. 
NO has a crucial role in the regulation of endothelial, 
controlling blood pressure, and cardiovascular hemostasis 
(10) by relaxing vascular and suppress platelet adhesion 
to vascular endothelium (11). The disorder can result in 
primary endothelial NO production is not enough that the 
vasoconstrictor factors are more dominant and higher blood 
pressure. Potential primary hypertension due to endothelial 
dysfunction can manifest in pregnancy and is called 
'vascular disorder of pregnancy'.(13)
 Diastolic pressure was more depicting base vascular 
tone, and NO plays a role in base vascular tone regulation 
as vasodilator substance (causing vascular relaxation).(11) 
NO large increase in diastolic pressure could be understood 
as a condition where the decrease of NO production was not 
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 Mean Arterial 
Pressure
r -0.08 -0.175 -0.136
p 0.786 0.309 0.427
r2 0.006 0.031 0.018
the main underlying cause of severe preeclampsia in this 
study subjects, in short, the main etiopathogenesis was not a 
vascular factor.  
 This study result did not prove that there was a 
correlation between L-citrulline levels with blood pressure. 
Another possibility to explain this fact was that the increase 
of blood pressure (occurrence of preeclampsia) in this 
study sample pathogenetically was not due to lack of 
NO production, lack of NOS3 enzyme activity, or due to 
downregulation  of  NOS  gene  due  to  polymorphism 
of NOS3 gene (especially at G-984 and T-786).(10) There 
is a relationship between the presences of the gene NOS3 
Single-nucleotide polymorphism T-786 (SNP T-786) 
with the occurrence of preeclampsia.(14) This could 
be elucidated if a further study was done in this study 
subjects to examine the association between NOS3 gene/
polymorphism of the NOS3 gene, NOS3 enzyme level, 
L-citrulline level, and blood pressure.  If those studies were 
also  proven  to  be  wrong,  it  could  be  concluded  that  the 
main etiopathogenesis of preeclampsia in this study subjects 
was not due to vascular factor.
Conclusion
This study proved that L-citrulline levels doesn’t correlate 
with  severe  preeclampsia.  Increase  of  blood  pressure 
was not due to lack of NO production that reflected by 
L-citrulline level.
Acknowledgements
We would like to thank all staff at Dr. M. Djamil Central 
General Hospital, Padang, Indonesia who had facilitated us 
in data collection. We would also like to thank all staffs of 
Biochemistry Laboratory, Faculty of Medicine, Universitas 
Andalas who had facilitated us in the processing of study 
samples. 
1.  Abalos E, Cuesta C, Grosso AL, Chou D, Say L. Global and regional 
estimates of preeclampsia and eclampsia: a systematic review. Eur 
J Obstet Gynecol Reprod Biol. 2013; 170: 1-7. doi: 10.1016/j.
ejogrb.2013.05.005.
2. Jeyabalan A. Epidemiology of preeclampsia: impact of obesity. Nutr 
Rev. 2013; 71: 18-25. 
3. Osungbade KO, Ige OK. Public health perspectives of preeclampsia in 
developing countries: implication for health services strengthening. 
J Pregnancy. 2011; 2011:481095. doi: 10.1155/2011/481095. 
4. Perpustakaan Fakultas Kedokteran Universitas Indonesia. Prevalensi 
preeklampsia berat di Rumah Sakit Ciptomangunkusumo. Jakarta: 
Perpustakaan Fakultas Kedokteran Universitas Indonesia; 2014.
5. Serudji J. Minimizing the occurrence and complications of 
preeclampsia: prevention and prediction. In: Pertemuan Ilmiah 
Tahunan (PIT) Fetomaternal XIII 2012 Mar 10-14, Palembang. 
Palembang: PIT Fetomaternal; 2012. 
6.  Matsubara K, Higaki T, Matsubara Y, Nawa A. Nitric oxide and 
reactive oxygen species in the pathogenesis of preeclampsia. Int J 
Mol Sci. 2015; 16: 4600-14.
7.  Johal T, Lees CC, Everett TR, Wilkinson IB. The nitric oxide pathway 
and possible therapeutic options in pre-eclampsia. Br J Clin 
Pharmacol. 2014; 78: 244–57.
8.  Hess S, Baker G, Gyenes G, Tsuyuki R, Newman S, Le Melledo 
J. Decreased serum L-arginine and L-citrulline levels in major 
depression. Psychppharmacology. 2017; 234: 3241-7.
9 Benedetto C, Marozio L, Neri I, Giarola M, Volpe A, Facchinetti F. 
Increased L-citrullinel-arginine plasma ratio in severe preeclampsia. 
Obstet Gynecol. 2000; 96: 395-9.
10. Zeng F, Zhu S, Wong MC, Yang Z, Tang J, Li K, et al. Associations 
between nitric oxide synthase 3 gene polymorphisms and 
preeclampsia risk: a meta-analysis. Sci Rep. 2016; 6: 23407. doi: 
10.1038/srep23407.
11. Rai H, Parveen F, Kumar S, Kapoor A, Sinha N. Association of 
endothelial nitric oxide synthase gene polymorphisms with coronary 
artery disease: an updated meta-analysis and systematic review. 
PLoS One. 2014; 9: e113363. doi: 10.1371/journal.pone.0113363.
12. Treuer AV and Gonzalez DR. Nitric oxide synthases, s-nitrosylation 
and cardiovascular health: from molecular mechanisms to 
therapeutic opportunities. Mol Med Rep. 2015; 11: 1555-65. 
13. Berhan Y. No hypertensive disorder of pregnancy; no preeclampsia-
eclampsia; no gestational hypertension; no. Hellp syndrome. 
Vascular disorder of pregnancy speaks for all. Ethiop J Health Sci. 
2016; 26: 177-86. 
14. Chen M, Tang W, Hou L, Liu R, Dong Z, Han X, et al. Tumor necrosis 
factor (TNF) -308G> A, nitric oxide synthase 3 (NOS3) + 894G> T 
polymorphisms and migraine risk: a meta-analysis. PlosOne. 2015; 
10: e0129372. doi: 10.1371/journal.pone.0129372.
References
